Skip to main content
Top
Published in: Breast Cancer Research and Treatment 2/2009

01-07-2009 | Epidemiology

Association between IGF1 CA microsatellites and mammographic density, anthropometric measures, and circulating IGF-I levels in premenopausal Caucasian women

Authors: Gordon Fehringer, Hilmi Ozcelik, Julia A. Knight, Andrew D. Paterson, Norman F. Boyd

Published in: Breast Cancer Research and Treatment | Issue 2/2009

Login to get access

Abstract

Background Results from several studies indicate that mammographic density, a strong risk factor for breast cancer, is greater in premenopausal women with higher circulating IGF-I levels. Both mammographic density and circulating IGF-I levels appear to be partly heritable traits. We hypothesized that in premenopausal women, IGF1 variants are associated with circulating IGF-I concentration, which in turn influences variation in breast density. Therefore, we examined the association of IGF1 polymorphisms with circulating IGF-I levels and mammographic density. Methods Percentage density, amounts of dense and non-dense (fat) tissue, IGF-I levels, and BMI were measured in 163 premenopausal women. Three CA repeat polymorphisms were genotyped, one each at the 5′ and 3′ ends of IGF1 and one in intron 2. Results The number of 19 alleles at the 5′ polymorphism was associated with lower circulating levels of IGF-I (P = 0.02), whereas the number of 185 alleles at the 3′ polymorphism was associated with higher percentage density (P = 0.03) and a smaller amount of non-dense tissue (P = 0.02). The strength of the effect of the 185 allele at 3′ on percentage density was greatly reduced and statistical significance lost when BMI was included in regression models. Conclusions Our results suggest an association between the number of 185 alleles at 3′ with percentage density. This association appears to be mediated by body composition and particularly body fat, as indicated by the association of 3′ IGF1 genotype with non-dense (fat) tissue and the mediating effect of BMI on the association of 3′ genotype with percentage density.
Appendix
Available only for authorised users
Literature
2.
6.
go back to reference Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60(14):3744–3748PubMed Byrne C, Colditz GA, Willett WC, Speizer FE, Pollak M, Hankinson SE (2000) Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 60(14):3744–3748PubMed
7.
go back to reference Maskarinec G, Takata Y, Chen Z, Gram IT, Nagata C, Pagano I et al (2007) IGF-I and mammographic density in four geographic locations: a pooled analysis. Int J Cancer 121(8):1786–1792. doi:10.1002/ijc.22834 PubMedCrossRef Maskarinec G, Takata Y, Chen Z, Gram IT, Nagata C, Pagano I et al (2007) IGF-I and mammographic density in four geographic locations: a pooled analysis. Int J Cancer 121(8):1786–1792. doi:10.​1002/​ijc.​22834 PubMedCrossRef
8.
go back to reference Verheus M, Peeters PH, Kaaks R, van Noord PA, Grobbee DE, van Gils CH (2007) Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause. Cancer Epidemiol Biomarkers Prev 16(3):451–457. doi:10.1158/1055-9965.EPI-06-0642 PubMedCrossRef Verheus M, Peeters PH, Kaaks R, van Noord PA, Grobbee DE, van Gils CH (2007) Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause. Cancer Epidemiol Biomarkers Prev 16(3):451–457. doi:10.​1158/​1055-9965.​EPI-06-0642 PubMedCrossRef
9.
go back to reference dos Santos Silva I, Johnson N, De Stavola B, Torres-Mejia G, Fletcher O, Allen DS et al (2006) The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 15(3):449–455. doi:10.1158/1055-9965.EPI-05-0555 PubMedCrossRef dos Santos Silva I, Johnson N, De Stavola B, Torres-Mejia G, Fletcher O, Allen DS et al (2006) The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 15(3):449–455. doi:10.​1158/​1055-9965.​EPI-05-0555 PubMedCrossRef
10.
go back to reference Lai JH, Vesprini D, Zhang W, Yaffe MJ, Pollak M, Narod SA (2004) A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. Cancer Epidemiol Biomarkers Prev 13(4):573–582PubMed Lai JH, Vesprini D, Zhang W, Yaffe MJ, Pollak M, Narod SA (2004) A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density. Cancer Epidemiol Biomarkers Prev 13(4):573–582PubMed
11.
go back to reference Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J et al (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98(11):2612–2615. doi:10.1172/JCI119081 PubMedCrossRef Harrela M, Koistinen H, Kaprio J, Lehtovirta M, Tuomilehto J, Eriksson J et al (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98(11):2612–2615. doi:10.​1172/​JCI119081 PubMedCrossRef
12.
go back to reference Hong Y, Pedersen N, Brismar K, Hall K, de Faire U (1996) Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab 81(5):1791–1797. doi:10.1210/jc.81.5.1791 PubMedCrossRef Hong Y, Pedersen N, Brismar K, Hall K, de Faire U (1996) Quantitative genetic analyses of insulin-like growth factor I (IGF-I), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. J Clin Endocrinol Metab 81(5):1791–1797. doi:10.​1210/​jc.​81.​5.​1791 PubMedCrossRef
13.
go back to reference Cleveland RJ, Gammon MD, Edmiston SN, Teitelbaum SL, Britton JA, Terry MB et al (2005) IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis 27(4):758–765. doi:10.1093/carcin/bgi294 PubMedCrossRef Cleveland RJ, Gammon MD, Edmiston SN, Teitelbaum SL, Britton JA, Terry MB et al (2005) IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis 27(4):758–765. doi:10.​1093/​carcin/​bgi294 PubMedCrossRef
14.
15.
16.
go back to reference DeLellis K, Ingles S, Kolonel L, McKean-Cowdin R, Henderson B, Stanczyk F et al (2003) IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br J Cancer 88(2):277–282. doi:10.1038/sj.bjc.6600728 PubMedCrossRef DeLellis K, Ingles S, Kolonel L, McKean-Cowdin R, Henderson B, Stanczyk F et al (2003) IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Br J Cancer 88(2):277–282. doi:10.​1038/​sj.​bjc.​6600728 PubMedCrossRef
17.
go back to reference Figer A, Karasik YP, Baruch RG, Chetrit A, Papa MZ, Sade RB et al (2002) Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women. Isr Med Assoc J 4(10):759–762PubMed Figer A, Karasik YP, Baruch RG, Chetrit A, Papa MZ, Sade RB et al (2002) Insulin-like growth factor I polymorphism and breast cancer risk in Jewish women. Isr Med Assoc J 4(10):759–762PubMed
18.
go back to reference Missmer SA, Haiman CA, Hunter DJ, Willett WC, Colditz GA, Speizer FE et al (2002) A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer 100(3):332–336. doi:10.1002/ijc.10473 PubMedCrossRef Missmer SA, Haiman CA, Hunter DJ, Willett WC, Colditz GA, Speizer FE et al (2002) A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer 100(3):332–336. doi:10.​1002/​ijc.​10473 PubMedCrossRef
21.
24.
go back to reference Liu K, Muse SV (2005) PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 21(9):2128–2129PubMedCrossRef Liu K, Muse SV (2005) PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 21(9):2128–2129PubMedCrossRef
25.
go back to reference SAS Institute Inc (1999–2001) SAS release 8.02 (1999–2001). SAS Institute Inc, Cary SAS Institute Inc (1999–2001) SAS release 8.02 (1999–2001). SAS Institute Inc, Cary
26.
go back to reference Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53(2):79–91. doi:10.1159/000057986 PubMedCrossRef Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53(2):79–91. doi:10.​1159/​000057986 PubMedCrossRef
27.
go back to reference Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL et al (2002) A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes 51(7):2313–2316. doi:10.2337/diabetes.51.7.2313 PubMedCrossRef Frayling TM, Hattersley AT, McCarthy A, Holly J, Mitchell SM, Gloyn AL et al (2002) A putative functional polymorphism in the IGF-I gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes 51(7):2313–2316. doi:10.​2337/​diabetes.​51.​7.​2313 PubMedCrossRef
29.
go back to reference Hadsell DL (2003) The insulin-like growth factor system in normal mammary gland function. Breast Dis 17:3–14PubMed Hadsell DL (2003) The insulin-like growth factor system in normal mammary gland function. Breast Dis 17:3–14PubMed
30.
go back to reference Slattery ML, Baumgartner KB, Byers T, Guiliano A, Sweeney C, Herrick J et al (2005) Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women. Cancer Causes Control 16(10):1147–1157. doi:10.1007/s10552-005-0318-2 PubMedCrossRef Slattery ML, Baumgartner KB, Byers T, Guiliano A, Sweeney C, Herrick J et al (2005) Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women. Cancer Causes Control 16(10):1147–1157. doi:10.​1007/​s10552-005-0318-2 PubMedCrossRef
31.
go back to reference Jernstrom H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N et al (2001) Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 10(4):377–384PubMed Jernstrom H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N et al (2001) Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev 10(4):377–384PubMed
32.
go back to reference Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA et al (2005) IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 15(1):1–10. doi:10.1093/hmg/ddi398 PubMedCrossRef Al-Zahrani A, Sandhu MS, Luben RN, Thompson D, Baynes C, Pooley KA et al (2005) IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 15(1):1–10. doi:10.​1093/​hmg/​ddi398 PubMedCrossRef
33.
go back to reference Patel AV, Cheng I, Canzian F, Le Marchand L, Thun MJ, Berg CD et al (2008) IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer fisk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One 3(7):e2578. doi:10.1371/journal.pone.0002578 PubMedCrossRef Patel AV, Cheng I, Canzian F, Le Marchand L, Thun MJ, Berg CD et al (2008) IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer fisk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One 3(7):e2578. doi:10.​1371/​journal.​pone.​0002578 PubMedCrossRef
34.
go back to reference Johansson M, McKay JD, Wiklund F, Rinaldi S, Verheus M, van Gils CH et al (2007) Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels. J Clin Endocrinol Metab 92(12):4820–4826. doi:10.1210/jc.2007-0887 PubMedCrossRef Johansson M, McKay JD, Wiklund F, Rinaldi S, Verheus M, van Gils CH et al (2007) Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels. J Clin Endocrinol Metab 92(12):4820–4826. doi:10.​1210/​jc.​2007-0887 PubMedCrossRef
35.
go back to reference Diorio C, Brisson J, Berube S, Pollak M (2008) Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Cancer Epidemiol Biomarkers Prev 17(4):880–888. doi:10.1158/1055-9965.EPI-07-2500 PubMedCrossRef Diorio C, Brisson J, Berube S, Pollak M (2008) Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels. Cancer Epidemiol Biomarkers Prev 17(4):880–888. doi:10.​1158/​1055-9965.​EPI-07-2500 PubMedCrossRef
36.
go back to reference Verheus M, McKay JD, Kaaks R, Canzian F, Biessy C, Johansson M (2007) Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density. Breast Cancer Res Treat. doi:10.1007/s10549-007 PubMed Verheus M, McKay JD, Kaaks R, Canzian F, Biessy C, Johansson M (2007) Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density. Breast Cancer Res Treat. doi:10.​1007/​s10549-007 PubMed
37.
go back to reference Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Rinaldi S et al (2006) Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer 94(2):299–307. doi:10.1038/sj.bjc.6602936 PubMedCrossRef Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Rinaldi S et al (2006) Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer 94(2):299–307. doi:10.​1038/​sj.​bjc.​6602936 PubMedCrossRef
38.
go back to reference Palles C, Johnson N, Coupland B, Taylor C, Carvajal J, Holly J et al (2008) Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy. Hum Mol Genet 17(10):1457–1464. doi:10.1093/hmg/ddn034 PubMedCrossRef Palles C, Johnson N, Coupland B, Taylor C, Carvajal J, Holly J et al (2008) Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy. Hum Mol Genet 17(10):1457–1464. doi:10.​1093/​hmg/​ddn034 PubMedCrossRef
39.
go back to reference Voorhoeve PG, van Rossum EF, Te Velde SJ, Koper JW, Kemper HC, Lamberts SW et al (2006) Association between an IGF-I gene polymorphism and body fatness: differences between generations. Eur J Endocrinol 154(3):379–388. doi:10.1530/eje.1.02101 PubMedCrossRef Voorhoeve PG, van Rossum EF, Te Velde SJ, Koper JW, Kemper HC, Lamberts SW et al (2006) Association between an IGF-I gene polymorphism and body fatness: differences between generations. Eur J Endocrinol 154(3):379–388. doi:10.​1530/​eje.​1.​02101 PubMedCrossRef
40.
go back to reference Sweeney C, Murtaugh MA, Baumgartner KB, Byers T, Giuliano AR, Herrick JS et al (2005) Insulin-like growth factor pathway polymorphisms associated with body size in Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 14(7):1802–1809. doi:10.1158/1055-9965.EPI-05-0149 PubMedCrossRef Sweeney C, Murtaugh MA, Baumgartner KB, Byers T, Giuliano AR, Herrick JS et al (2005) Insulin-like growth factor pathway polymorphisms associated with body size in Hispanic and non-Hispanic white women. Cancer Epidemiol Biomarkers Prev 14(7):1802–1809. doi:10.​1158/​1055-9965.​EPI-05-0149 PubMedCrossRef
41.
go back to reference Sun G, Gagnon J, Chagnon YC, Perusse L, Despres JP, Leon AS et al (1999) Association and linkage between an insulin-like growth factor-1 gene polymorphism and fat free mass in the HERITAGE Family Study. Int J Obes Relat Metab Disord 23(9):929–935. doi:10.1038/sj.ijo.0801021 PubMedCrossRef Sun G, Gagnon J, Chagnon YC, Perusse L, Despres JP, Leon AS et al (1999) Association and linkage between an insulin-like growth factor-1 gene polymorphism and fat free mass in the HERITAGE Family Study. Int J Obes Relat Metab Disord 23(9):929–935. doi:10.​1038/​sj.​ijo.​0801021 PubMedCrossRef
43.
go back to reference Tamimi RM, Cox DG, Kraft P, Pollak MN, Haiman CA, Cheng I et al (2007) Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Res 9(1):R18. doi:10.1186/bcr1655 PubMedCrossRef Tamimi RM, Cox DG, Kraft P, Pollak MN, Haiman CA, Cheng I et al (2007) Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Res 9(1):R18. doi:10.​1186/​bcr1655 PubMedCrossRef
44.
go back to reference Chen TM, Kuo PL, Hsu CH, Tsai SJ, Chen MJ, Lin CW et al (2007) Microsatellite in the 3′ untranslated region of human fibroblast growth factor 9 (FGF9) gene exhibits pleiotropic effect on modulating FGF9 protein expression. Hum Mutat 28(1):98. doi:10.1002/humu.9471 PubMedCrossRef Chen TM, Kuo PL, Hsu CH, Tsai SJ, Chen MJ, Lin CW et al (2007) Microsatellite in the 3′ untranslated region of human fibroblast growth factor 9 (FGF9) gene exhibits pleiotropic effect on modulating FGF9 protein expression. Hum Mutat 28(1):98. doi:10.​1002/​humu.​9471 PubMedCrossRef
Metadata
Title
Association between IGF1 CA microsatellites and mammographic density, anthropometric measures, and circulating IGF-I levels in premenopausal Caucasian women
Authors
Gordon Fehringer
Hilmi Ozcelik
Julia A. Knight
Andrew D. Paterson
Norman F. Boyd
Publication date
01-07-2009
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2009
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-008-0146-7

Other articles of this Issue 2/2009

Breast Cancer Research and Treatment 2/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine